ANVISA Brazil - Successful Renewal - Ahmedabad Mehsana - Lambda CRO
ANVISA Accreditation renewed successfully for Lambda’s Ahmedabad and Mehsana Facilities
NEWS
A Bioequivalence Study of Pertuzumab 420 mg Solution for Infusion
Clinical Insights from a Bioequivalence Study of Pertuzumab 420 mg Solution for Infusion
blog
Bioanalytical Methods - Assay List | Lambda-Novum
Bioanalytical Assays – Methods Library
Lambda Therapeutic Research provides QPPV services across the EU and UK, offering companies a reliable framework to meet regulatory expectations and maintain inspection readiness at all times.
Qualified Person for Pharmacovigilance (QPPV): Strengthening Compliance Across the EU and UK
Qualified Person for Pharmacovigilance (QPPV): Strengthening Compliance Across the EU and UK
Lambda Therapeutic Research provides QPPV services across the EU and UK, offering companies a reliable framework to meet regulatory expectations and maintain inspection readiness at all times.
Case-study Phase-I Bioequivalence Study of Trastuzumab SC Injections - Lambda CRO India
Study Insights: Phase-I, Bioequivalence Study of Trastuzumab SC Injection
blog
Specialized Clinical Development Support for Semaglutide - GLP1 RA - CRO expertise
Specialized Clinical Development Support for Semaglutide Programs
blog
Bioanalytical Excellence Upheld - Unannounced US FDA inspection concludes with Zero 483s - Lambda CRO
Bioanalytical Excellence Upheld – Unannounced US FDA inspection concludes with Zero 483s
NEWS
Lambda Clears 4 Back-to-Back US FDA PV Inspections in 12 Months Without 483s
Lambda Successfully Completes US FDA Pharmacovigilance Inspection with Zero 483s – 4th Consecutive in One Year
NEWS
- 1
- 2
- 3
- 4
- …
- 12
- Go to the next page